Posted on February 4, 2016 | By Pharmacy OneSource
February 4, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today the release of a complimentary Antimicrobial Stewardship (AMS) Gap Analysis to help healthcare organizations evaluate and establish strategies for enhancing AMS programs in response to the National Action Plan for Combating Antibiotic Resistant Bacteria. The tool helps teams identify the most appropriate starting point and implementation option for upgrading programs based on past accomplishments.
Released in March 2015, the National Action Plan is a roadmap for slowing the emergence of resistant bacteria and preventing the spread of resistant infection through the appropriate use of vaccines, implementation of healthcare policies and antibiotic stewardship programs that improve care outcomes. Noting that prevention of resistance requires rapid detection and control of outbreaks at the hospital, community and regional levels, the plan also calls upon facilities to take action to minimize development of bacterial resistance by ensuring that each patient receives the right antibiotic at the right time and dose for the right duration.
Designed to help hospitals align AMS programs with national goals, the AMS Gap Analysis consists of a brief survey about a facility’s current program. Responses are then compared to standards established by national organizations like the Infectious Diseases Society of America and Society for Healthcare Epidemiology of America. Results establish the program’s overall maturity—infancy, intermediate or robust—and identify the most appropriate steps for enhancing performance.
For example, infancy stage programs will often benefit from expanding the AMS committee to include a broader array of disciplines, and from automating time-consuming paper records and manually created spreadsheets. Electronic systems can speed identification of patients who are at risk for infection or who may be receiving inappropriate antibiotics, and enable an increase in the frequency and specificity of the facility’s antibiogram.
Programs at the intermediate stage may be ready to implement new protocols for de-escalation, duplicative antibiotic review, mandatory 48-hour antibiotic stops without cultures that support a bacterial infection, and IV-to-PO conversion. Next steps might include documentation of all interventions and acceptance rates by provider or use of an electronic surveillance system to facilitate intervention reporting. Further, the addition of clinical decision support can help align antibiotic prescribing with established protocols for the narrowest agent capable of treating the indicated infection and help identify the proper dose and duration.
Even high-performing AMS programs can be enhanced, for example by encouraging professionals to obtain certification in antimicrobial stewardship or optimizing electronic surveillance systems for intervention reporting by pharmacists and providers. Depending on which components have already been implemented, it may also be appropriate to add a full-time infectious disease specialist.
The brief survey, which provides results upon completion, is available for download at Antimicrobial Stewardship Gap Analysis Survey.
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
Marketing Communications Director
Wolters Kluwer | Pharmacy OneSource
(425) 451-4063 ext.199
Written for clinicians